Line 1: | Line 1: | ||
− | {{Freiburg/Styles}} {{Freiburg/Menubar}} {{Freiburg/Away}} {{Freiburg/Main}} | + | {{Freiburg/Styles}} {{Freiburg/Menubar}} {{Freiburg/Away}} {{Freiburg/Main}} {{Freiburg/Top}} |
<html> | <html> | ||
<div class="column full_size"> | <div class="column full_size"> |
Revision as of 15:30, 17 October 2016
Lab Summary
We want to use the endospores of Bacillus subtilis as a carrier vessel for a prodrug activating enzyme and a nanobody to improve the targeted drug delivery system.
Bacillus subtilis builds these spores under distressed conditions (such as nutrition deficiency). The spores are highly resistant to heat, UV-light and are easy to handle.
We modified the spores in their coat proteins so that they are expressing the fusion proteins, the Glutathione S-Transferase (GST) and nanobody, on their surface. We experimented with modifications on the genes CotZ, CgeA,CotG and CotB, to see where we could achieve the optimal conditions.